Cempra (CEMP) on Watch as FDA Briefing Docs Published

November 2, 2016 8:28 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Cempra (NASDAQ: CEMP) FDA briefing documents are out. LINK

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

FDA, Trader Talk

Add Your Comment